Clinical Trials
77 trialsTumor TARGET Prostate Cancer
University Health Network, Toronto
Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma
Mahidol University
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
Icahn School of Medicine at Mount Sinai
Acute Toxicity After Moderate Hypo-fractionated Intensity Modulated Radiotherapy IMRT or Prostate Cancer
Mansoura University Hospital
Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
Massachusetts General Hospital
Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer
Laibin People's Hospital
PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma
Sun Yat-sen University
CONTINUUM
Sun Yat-sen University
Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma
Guilin Medical University, China
Metabolomic Study for Localized Prostate Cancer
Georgetown University
Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer
Georgetown University
PICCRT
Guangdong Provincial People's Hospital
Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC
National Cancer Centre, Singapore
Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomics
Xiangya Hospital of Central South University
iPLENTY-pvtt
RenJi Hospital
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
Fudan University
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer
Xi'an Jiaotong University
Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma
Sun Yat-sen University
Neo-RT
Cambridge University Hospitals NHS Foundation Trust
Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Sun Yat-sen University
Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
RELIEF
Shanghai Chest Hospital
BJCC-R01
Peking University Cancer Hospital & Institute
Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.
The First Affiliated Hospital of Dalian Medical University
Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial
Sun Yat-sen University
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen
Peking University Cancer Hospital & Institute
Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma
First People's Hospital of Foshan
Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
West China Hospital
A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer
West China Hospital
Hypofractionated Radiation Therapy in Prostate Cancer
University Hospital, Geneva
Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI
University Hospital, Geneva
Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Sun Yat-sen University
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients
Sun Yat-sen University
Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC
Tianjin Medical University Cancer Institute and Hospital
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
the Re-irradiation of Recurrent Cervical Cancer by IMRT
Sun Yat-sen University
Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma
Guilin Medical University, China
Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer
Guiyang Medical University
Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Guilin Medical University, China
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
DUCRO-HN
Azienda Ospedaliero-Universitaria Careggi
Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
Fudan University
IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer
Guizhou Medical University
the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer
Guiyang Medical University
TomoBreast
Vrije Universiteit Brussel
IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma
Nanfang Hospital, Southern Medical University
Intensity-modulated Radiotherapy Protocol in Cervix Cancer
Seoul St. Mary's Hospital